New appointment at Calistoga
This article was originally published in Scrip
Executive Summary
Calistoga Pharmaceuticals (US) has named Langdon Miller executive vice-president of R&D. Dr Miller has more than 20 years' drug development experience, with previous roles including chief medical officer at PCT Therapeutics and vice-president of global oncology clinical research at Pharmacia.